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SUMMARY.-Whereas dilute solutions of surface active agents modify the
properties of cell membranes, particularly in relation to their electrical
behaviour, moderate and strong solutions provoke more serious structural
damage of the membrane, leading to an increase of its permeability and, finally,
to cytolysis. These phenomena have inspired some authors to apply detergents
as possible cancer chemotherapeuticals so far, however, with only poor results.
The disintegrating effect oftumouremboli into single cells by certain detergents,
and the ingenious discovery that the mutual adhesiveness between cancercells is
much less than between normal cells, have led the present authors to investigate
the action of some biological surface active agents, alone as well as in some of
their associations on the " take " of Yoshida sarcoma implants. Certain
associations showed, in contradistinction to the separately applied components,
surprisingly favourable activity. It could be established that a correlation
actually exists between inhibitory effect and surface activity.
HAEMOLYSIS as a manifestation ofthe cytolytic activity ofsurface active agents
was early recognized to be a consequence of cell membrane damage (Valko, 1946;
Hotchkiss, 1946; Bennett and Connon, 1957; Hodes et al., 1960). The nature of
such damage must of course be directly related to the structural composition ofthe
membranes, about which an ever-increasing amount of information has become
available (Fishman, 1962; Van Deenen, 1965; Kumerow, 1965; Biochimica et
Biophysica Acta, 1967, 1968, 1969; Northcote, 1968 and Chapman, 1968). It is
for example, now well-established that cell membranes are principally composed of
proteins, phospholipids and cholesterol, and it has been repeatedly confirmed that
it is, in fact, exactly these components that are affected by the action ofdetergents.
The denaturating or disarranging effect ofsurface active agents on proteins was
discovered as early as 1939 by Anson. This denaturation should be due to the
unfolding and disruption of the protein molecules (Anson, 1939; Hober and
Hober, 1942), whereas in case of conjugated proteins, the bonds between the
protein part and the prosthetic group are severed (Anson, 1939; Kuhn, 1940).
Leakage of N-containing substances out of the attacked cells could be observed
(Hotchkiss, 1946), probably due to the removal of soluble nucleotides and amino
acids (Kay, 1965). Furthermore, the proper detergent is able to combine with the
membrane proteins aind/or lipids (Valko, 1946; Ponder, 1948 and Hodes et al.,
1960). As to the latter membrane components, phospholipids are, at least in part,
released from the cell membrane by detergents (Rideal and Taylor, 1957) as also
happens with cholesterol (Barrett and Hodes, 1960). It is understandable, then,
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increases in permeability (Hober and Hober, 1942; Kaltenbach et al., 1958; Hodes
et al., 1960) or " becomes thinner " (Yamada et al., 1963) which finally leads to the
complete disintegration (lysis) of the cell as a whole (Kishimoto and Adelman,
1964).
However, before these drastic modifications take place, the cell membrane
undergoes other, less serious changes in its behaviour, as a consequence of the
action of (very) dilute solutions of the detergent. One of the most specific pro-
perties of surface active agents is that they concentrate as oriented layers upon
interfaces (Becher, 1961) so that already extremely low concentrations (Hotchkiss,
1946), down to 1: 7 000*000 (Ambrose et al., 1958), actually do affect the mem-
brane's normal properties.
According to Kishimoto and Adelman (1964), the detergent molecules are
adsorbed first at the surface of the cell membrane by forming complexes with the
membrane substructure, causing changes in the electrical potential. In addition,
Seufert (1965) observed that the electrical resistance of the cell membrane is con-
siderably decreased by all types of detergents, e.g. anionic, cationic, non-ionic and
amphoteric, as a consequence of an increase of the membrane's electrical potential
which means nothing else than an increase ofthe mutual repulsion between the cells
and, hence, a decrease of the adhesiveness of the cells, both to each other and to
other similarly charged structures.
It has been repeatedly attempted, including in the field of cancer, to take
practical advantage ofthe above mentionedactivities ofdetergents. Theincreased
permeability of the cell membrane, for example, has inspired attempts to enhance
the action of antitumour agents (Morishita, 1963; Hanson and Bohley, 1968),
whilst the detergent's lytic action has stimulated the application of surfactants as
possible cancer chemotherapeuticals (Bennett and Connon, 1957; Hanson and
Bohley, 1968). However, the results obtained so far have been poor.
As far as could be ascertained from the literature, these attempts have only
involved separately applied detergents. This in spite of the well-known fact that
mixed detergents act in many cases much more efficiently than either one of the
components. In fact, many detergents mutually enhance their emulsifying
capacity (Schulman and Cockbain, 1940) and it is exactly for this reason that the
better emulsifiers are generally prepared by the association of two or more surface
active agents. Many almost ideal emulsifiers found in nature consist for the far
greater part ofextremely complex mixtures ofsurfactants (egg yolk is an excellent
example).
In this paper a few surface active agents, separately as well as combined, are
tested on their inhibitory action on the growth ofimplants ofthe Yoshida sarcoma
in rats. In contradistinction to the separately-applied surface active agents,
various mixtures or associations of the same substances showed a surprisingly
favourable inhibitory activity.
METHOD AND RESITLTS
Ten to 15 male Wistar rats with an initial weight of about 120 g. were used in
every experiment. The controls received a normal ration of pellets and tap water
ad libitum. Phospholipids (PL) were introduced in the drinking water, which
consisted of a 1 % emulsion of " Asolectin "* corresponding to a dose ofabout 1 g./
* "Asolectin' is a granulated purifiedl soybean phosphatide, kindly put at, our disposal by J
Eichberg, President of American Lecithin Company, Atlanta, U.S.A.
529R. F. A. ALTMAN, L. G. SPOLADORE AND E. L. ESCH
day/kg. body-weight. Cholesterol (Chol) was added to the ration containing, per
kg., 80 ml. babassu-fat* in which 4 g. ofChol was dissolved. This corresponds to a
dose of about 400 mg. Chol/day/kg. bodyweight. PL and Chol were usually
administered about 20 days before transplant ofthe Yoshida sarcoma. The other
drugs were introduced subcutaneously. The implants were accomplished in all
groups according to the method describedby Salter et al. (1958) (see also Spoladore,
1968), namely in the form ofa macerate with three parts of0 9% saline. One half
ml. of the obtained brei was injected in the right hind leg ofthe animal. Fifteen
days after transplant all animals were killed, weighed, the back legs skinned,
carefully disarticulated at the hip-joint, and removed. Tumour weights were
determined by subtracting from the weight ofthe tumour-bearing leg the weight of
the normal hind limb. In this communication, stress is only laid on the total
inhibition ofthe " take " ofthe transplanted tumour. The figures which express
the activity of surfactants on the development of the produced tumours in com-
parison with the control tumours will be published elsewhere.
The results are summarized in Table I from which the following conclusions can
be drawn:
1. When separately applied, the tested surface active agents show, if any, only
weak inhibitory activity (Experiments 1-6). In one case Insulin (Exp. 4b)
and Antistine (Exp. 5a) provoked a total inhibition of 22 and 40 % respec-
tively. These figures were, however, not reproducible.
2. The activity ofPL andInsulin in association (Exp. 7a, b, d) resulted in atotal
inhibition of 60 % of the implants " take ". In Exp. 7c this figure was
reduced to 46 % and in Exp. 7e even to zero, probably due to the application
of lower Insulin-doses, e.g. 0-8 respectively 0 5 U.
3. A surprisingly high percentage (91!) of total inhibition of the " take " was
obtained with the association ofPL, Insulin and Antistine (Exp. 8a). Even
when applied in the low dose of 0 5 U, Insulin combined with PL and
Antistine still showed a satisfactory inhibition of 60 % (Exp. 8b).
4. Glucagon showed about the same activity as Insulin when combined with
PL (Exp. 10) but the association PL-Insulin-Glucagon inhibited only for
25% (Exp. 9).
5. The inhibition resulting from the association PL-Antistine (Exp. 1la-c) was
only weak but, generally speaking, still better than the action of either one
ofthe components.
6. The same is true for Chol-Insulin associations (Exp. 12a, b). However, in
Exp. 12c an inhibition ofnot less than 83 % was obtained, exactly when only
0 5 U of Insulin was applied.
7. The addition of Antistine to the former association (Exp. 13) lowered the
inhibition percentage considerably. This is in flat contradistinction to the
combination PL-Insulin whereby the addition of Antistine favoured so
greatly the inhibitory effect.
8. Insulin and Glucagon act synergistically when combinedwith Chol (Exp. 14)
showing an inhibition of not less than 85 %. Curiously enough, as was
already stressed (see 4 above), Insulin and Glucagon, associated with PL,
could be recognized as real antagonists.
* Babassu-fat was a gift ofMoacyr Silva, Technical Director of " Carioca Industrial, S.A. ", Rio de
Janeiro.
530TABLE I.-Total Inhibition of the " Take " of Yoshida Sarcoma Transplants by
Separate and AssociatedSurface Active Agents
Important experimental data
Exp.
No.
1
2a
2b
2c
3a
3b
3c
4a
4b
4c
5a
5b
5c
6
Drug applied
None (controls)
PL alone
Chol alone
Insulin alone
Antistine alone
Glucagon alone
7a . PL+
Insulin
7b . PL+
Insulin
7c . PL+
Insulin
7d . PL+
Insulin
7e . PL+
Insulin
8a . PL+
Insulin+
Antistine
8b . PL+
Insulin+
Antistine
9 . PL+
Insulin+
Glucagon
10 . PL+
Glucagon
lla . PL+
Antistine
llb . PL+
Antistine
llc . PL+
Antistine
12a . Chol+
Insulin
12b . Chol+
Insulin
12c . Chol+
Insulin
13 . Chol+
Insulin
Antistine
14 . Chol+
Insulin+
Glucagon
15 . Chol+
Antistine
16 . Chol%
Glucagon
Duration of
drug administr.
(in days before and
after transplant*)
0+15
22+15
50+15
0+15
22+15
50+15
0+14
20+14
0+14
0+14
0+14
20+14
0+14
0+15
O+ 9
22+15
0+ 9
0+15
0+14
22+15
20+14
50+15
0+14
22+15
O+ 9
0+ 4:
50+15
0+14
0+14
50+15
0+14
0+14
50+15
0+14
0+15
0+14
22+15
20+14
50+15
0+14
22+15
0+ 9
22+15
20+14
50+15
0+14
50+15
0+14
0+14
,.
22+15
20+14
50+15
0+14
Daily dose
per rat
120-150 mg.
P,,
40-50 mg.
1-6U
* ,,0U
0-2 mg.
0-2 mg.
120-150 mg.
1-6U
120-150 mg.
0-8U
120-150 mg.
0.5U
120-150 mg.
1-6U
0-2 mg.
120-150 mg.
0.5U
0-2 mg.
120-150 mg.
0-5U
0-.2 mg.
120-150 mg.
0-2mg.
120-150 mg.
0-2 mg.
40-S50 mg.
1-6U
40-50 mg.
0-8U
4-S50 mg.
0-5U
40-S50 mg.
0.5U
0-2mg.
40-S50 mg.
0.5U
0-2 mg.
40-S50 mg.
0-2 mg.
40-S50 mg.
0 2mg.
* The designation
" 22+15
" etc. signifies 22 days before and 15 days after the transplant. None
of the animals received any injection on the day of transplant. The oral administration of PL and
Chol, however, continued uninterruptedly.
t Injected on alternative days.
$ In the columns " take " and " no take " are mentioned the actual numbers of rats surviving
15 days after transplant and (in brackets) the percentage numbers.
"Take "t
14 (100)
15 (100)
15 (100)
15 (100)
12 (86)
14 (93)
15 (100)
6 (100)
7 (78)
10 (100)
6 (60)
10 (100)
11 (92)
9 (100)
4 (40)
4 (40)
* 7 (54)
4 (40)
12 (100)
1 (9)
4 (40)
6 (75)
No
"take t
0 (0)
0 (0)
0 (0)
0 (0)
2 (14)
1 (7)
0 (0)
0 (0)
2 (22)
0 (0)
4 (40)
0 (0)
1 (8)
0 (0)
6 (60)
6 (60)
6 (46)
6 (60)
0 (0)
10 (91)
6 (60)
2 (25)
6 (46)
1 (12)
2 (22)
6 (46)
4 (36)
2 (22)
10 (83)
2 (17)
11 (85)
2 (20)
1 (10)
7
7
7
7
7
7
2
10
(54)
(88)
(78)
(54)
(64)
(78)
(17)
(83)
2 (15)
8 (80)
9 (90)
-R. F. A. ALTMAN, L. G. SPOLADORE AND E. L. ESCH
9. Chol, associated either with Antistine or with Glucagon, showed practically
no activity as was the case with Chol alone (cf. Exp. 3a-c with 15-16).
In order to establish whether a correlation exists between surface activity and
inhibitory effect on the " take " of implants, surface tension determinations were
made ofAsolectin, Insulin and Antistine, alone and in association. The complete
results will be reported elsewhere, but the minimum value obtainable by ade-
quately combining the aqueous solutions of the three components is of interest
here. The following values of the surface tension (in dynes/cm. at 310 C.) are
remarkable:
Water: 69-95
Asolectin 1 % (a): 51-33
Insulin 03 U/ml. (b): 53-63
Antistine 02 % (c): 58-42
99-25 parts of (a) + 075 parts of (b): 47-45
98*01 parts of (a) + 074 parts of (b) + 1-25 parts of (c): 35-46
In these figures confirmation can be found that the surface activity ofthe tested
compounds actually does account for their ability to inhibit the development of
transplanted tumours. This is, for the rest, in agreement with the correlation
earlier reported by Hotchkiss (1946) and by Hober and Hober (1942) between the
surface activity and the cytolytic power of detergents.
DISCUSSION
The above experimental results clearly demonstrate that some associations of
the surface active agents studied show, in contradistinction to their separate com-
ponents, an accentuated inhibitory effect on the " take " of the Yoshida sarcoma.
Furthermore, the existence of a correlation between this inhibitory effect and the
surface activity could be established. This latter finding represents an easy and
rapid screening method for the determination of the activity of all sorts of deter-
gents and their associations.
The question now arises in what way detergents do inhibit so efficiently the
"take " of transplants.
Our own work (Altman, 1962, 1968), as well as that most instructive paper of
Abercrombie and Ambrose (1962) in which so many fundamental findings have
been reviewed, already emphasized the utmost importance of cell surfaces in
phenomena related to cancer. The spectacular observation made by Coman
(1944) that mutual adhesiveness is much less between carcinoma cells than between
normal cells could, in later years, be ascribed to the higher average charge density
oftumour cells in comparison with that ofnormal cells from which they have been
derived (Ambrose et al., 1956; Yamada, 1962b). In fact, an increase ofthe electri-
cal potential of the cell membranes must provoke an increase of the mutual
repulsion between the cells which means nothing else than a decrease of their
adhesiveness (see the Introduction). Therefore, surface active agents, capable of
decreasing mutual adhesiveness, do in the first instance affect tumour cells which
adhere much less than normal cells. It is quite conceivable then, that under the
influence of surfactants the adhesiveness between cancer cells reaches such a low
value that the tumour disintegrates into single cells. Indeed, Yamada (1962a)
proved experimentally (in vitro) the dissociation in single cells ofwhat he has called
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"hepatoma islands " by some Tweens in low (1 %) concentration. Thereby, the
very important observation could be made that the obtained single cells, lysis of
which only occurred by the use of higher (5-10 %) Tween-concentrations, did not
lose their viability in 57 % of the cases.
In attempting to clarify the mechanism ofthe inhibitory activityofsurfactants
on the " take " of implants, it is most likely that the introduced tumour meets in
the new environment a somewhat higher charge density due to the administration
of either phospholipids or cholesterol (both are surface active agents) to the recipi-
ent animals before transplant. After transplant, these animals received, in addi-
tion, the other surfactants which, as could so clearly be demonstrated, act
synergistically.
Thus, the charge density of the introduced tumour as well as of the host's
tissues increases in such a manner that the repulsion of the tumour cells mutually
and to other similarly charged tissues, reaches such a high value that the attach-
ment ofthe tumour cells is impeded or, in other words, the " take " ofthe implant is
inhibited. It is, then, comprehensible why the introduction of phospholipids in
association with Insulin (Exp. 7a and 7c) is still effective, even when started only
on the day following transplant.
Seemingly, the observed favourable effect of surfactants has only limited
practical value. In the first place, attention has been called (Seufert, 1965) to the
temporary character of the capability of detergents to increase the electrical
potential of cell membranes. This means that, in order to prevent permanently
the " take " ofimplants, the recipient animal must continuously be treated by the
detergents. In our experiments, indeed, all animals were killed 15 days after
transplant, during which short period the surfactants had been daily introduced.
Another limiting factor is, perhaps, that the viability ofthe introduced cancer cells
is not affected in 57 % of the cases (Yamada, 1962a). It is true that this figure
concerns in vitro experiments and it is not impossible that this percentage, due to
the defensive power ofthe organism, would be considerably lower in tests executed
in vivo.
However, in spite of the above-mentioned limiting factors, the powerful
inhibiting action on the " take " ofimplants by associated surface active agents may
open a completely new and possibly fertile field in cancer research. It is, for
example, possible that these agents could represent a valuable means for the
prevention of metastasis formation. The high charge density produced may
impede the coalescence of single tumour cells to form tumour emboli which,
furthermore, would be prevented from settling down (anchoring) in places favour-
able for their growth. Experiments, extended to a series of other biological
surface active agents, are now in progress in order to study the various problems
related to the practical application of our finding.
The authors are indebted to V. C. do Amaral and F. Correa Filho for their
invaluable technical assistance.
This work was supported by a grant ofthe Brazilian National Research Council
(" Conselho Nacional de Pesquisas "), Rio de Janeiro.
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